Upcoming IPO
Emcure Pharmaceuticals IPO: Allotment Details, IPO Date, Review, Price
A new explosion is about to happen in the pharmaceutical industry! Emcure Pharmaceuticals is preparing for its IPO, and this news is creating buzz in the pure investment world. Well, let us know everything about this IPO, so that you can decide whether to invest or not.
About the Company
Emcure Pharmaceuticals is a leading Indian pharmaceutical company which is showing its presence all over the world. This company makes medicines, manufactures them, and sells them all over the world.
- 13th largest pharmaceutical company in India (according to Domestic Sales, MAT in Financial Year 2024)
- Apne Covered Markets mein 4th largest pharmaceutical company
- India’s largest pharmaceutical company in terms of gynecology and HIV antivirals.
Emcure’s secret weapon is its varied product portfolio. They make medicines for major diseases, such as gynecology, heart disease, vitamins, HIV, blood related problems, and cancer. The chronic diseases market is set to expand rapidly in the future, and Emcure already holds a strong position in the field.
Also Read: Hyundai Motor India IPO Allotment Details, Date, Review, Price
IPO Details
The IPO of Emcure Pharmaceuticals is scheduled to be launched on July 3, 2024. Let’s see some important details about it:
| Thing | Details |
|---|---|
| Total IPO Size | ₹1,952.03 Crores |
| New Shares | ₹800 Crores (7,936,507 Shares) |
| Old Shares for Sale | ₹1,152.03 Crores (11,428,839 Shares) |
| Share Face Value | ₹10 per Share |
| Share Price | Between ₹960 and ₹1,008 per Share |
| Minimum Shares to Buy | 14 Shares |
| Where Shares Will Be Listed | BSE & NSE |
The company says it will use the money from new shares to:
- Pay off old loans
- Do general company work
Important Dates
Mark these dates on your calendar:
| Event | Date |
|---|---|
| IPO Starts | July 3, 2024 |
| IPO Ends | July 5, 2024 |
| Share Allotment Decision | July 8, 2024 |
| Money Refund Starts | July 9, 2024 |
| Shares Added to Accounts | July 9, 2024 |
| Shares Start Trading | July 10, 2024 |
Company’s Money Matters
Let’s look at how much money the company made and spent in the last few years:
| Year | Money Earned (₹ in Crores) | Money Spent (₹ in Crores) | Profit (₹ in Crores) |
|---|---|---|---|
| 2022 | 5,918.86 | 4,946.31 | 702.56 |
| 2023 | 6,031.72 | 5,278.36 | 561.85 |
| 2024 | 6,715.24 | 5,978.08 | 527.58 |
The company is earning more money each year, but its profit is going down a bit. This is something to think about.
IPO Value
Here are some numbers that help us understand the company’s value:
| Thing | Value |
|---|---|
| Earning Per Share (EPS) | ₹27.54 per Share |
| Price/Earning (P/E) Ratio | Not available yet |
| Return on Net Worth (RoNW) | 16.87% |
| Net Asset Value (NAV) | ₹163.22 per Share |
P/E ratio is not known yet, so it is a bit difficult to compare with other companies. Return on Net Worth of 16.87% shows that the company is performing well.
How to Apply
If you are thinking of investing in IPO, this is the way to go:
- ASBA (Application Supported by Blocked Amount): You can apply online through your bank account or stock broker.
- Through UPI: UPI (Unified Payments Interface): If you are a retail investor, you can also apply through UPI.
- Offline Application: Old method, form can be given to bank or broker.
Here’s how to apply through popular investment apps:
How to apply from popular investment platforms zerodha
- Log in to Zerodha
- Go to Portfolio > IPO
- Choose “Emcure Pharmaceuticals”
- Enter your UPI ID, how many shares you want, and the price
- Submit your application
- Approve the payment in your UPI app
Upstox
- Log in to the Upstox app
- Go to the IPO section
- Choose “Emcure Pharmaceuticals”
- Enter your details
- Confirm your application
- Approve the payment in your UPI app
Paytm Money
- Log in to Paytm Money app
- Go to the IPO section
- Choose “Emcure Pharmaceuticals”
- Enter your details
- Confirm your application
- Approve the payment in your UPI app
Remember, you must buy at least 14 shares. If you apply at the highest price, you’ll need to invest at least ₹14,112. You can invest up to ₹197,568 for 196 shares.
Other Similar Companies
Emcure isn’t the only medicine company. Here are some other big ones:
- Dr. Reddy’s Laboratories Limited
- Cipla Limited
- Alkem Laboratories Limited
- Torrent Pharmaceuticals Limited
- Mankind Pharma Limited
- Abbott India Limited
- J. B. Chemicals & Pharmaceuticals Limited
It’s good to learn about these companies too, to understand how Emcure compares to them.
What Experts Say
A company called Swastika Investmart says people should apply for this IPO. But remember, this is just one opinion. It’s important to do your own research too.
Common Questions
Here are some questions people often ask:
- What’s the price range for the IPO?
Between ₹960 and ₹1,008 per share. - When does the IPO start and end?
It starts on July 3, 2024, and ends on July 5, 2024. - What’s the least amount of money I need to invest?
₹14,112 (for 14 shares at the highest price). - When will I know if I got the shares?
On July 8, 2024. - When can I start buying and selling these shares?
From July 10, 2024, on BSE and NSE. - Who’s managing this IPO?
Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited. - Is there a discount for company employees?
Yes, eligible employees get a ₹90 discount per share.
Conclusion
An intriguing chance to invest in the pharmaceutical industry appears to be the IPO of Emcure Pharmaceuticals. The company is likely to grow in the future, and it enjoys a strong market position with a diversified product portfolio.
Remember that every investment carries some risk. It is important to remember that over the past ten years, the company’s profit has somewhat declined. Read the company’s Red Herring Prospectus (RHP), consult a financial advisor, and consider your risk tolerance before making an IPO investment. However, time will tell whether or not this is a real investment. So, friends, make decisions based on society and reason. If you think Emcure has a bright future, you should take part in the IPO.
